These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10097506)

  • 1. [Therapy of cardio-neurotic diseases in general practice: clinical experience with atarax].
    Smulevich AB; Syrkin AL; Drobizhev MIu; Ivanov SV; Lebedeva OI; Andreev AM
    Klin Med (Mosk); 1999; 77(1):43-6. PubMed ID: 10097506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Atarax in treatment of anxiety in outpatient clinic].
    Bobrov AE; Babin AG; Gladyshev OA; Belianchikova MA; Piatnitskiĭ NIu; Bakalova EA; Abolmasova OB
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(2):31-3. PubMed ID: 9532714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition and treatment of depression and anxiety in patients with acute myocardial infarction.
    Huffman JC; Smith FA; Blais MA; Beiser ME; Januzzi JL; Fricchione GL
    Am J Cardiol; 2006 Aug; 98(3):319-24. PubMed ID: 16860016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice.
    Nguyen N; Fakra E; Pradel V; Jouve E; Alquier C; Le Guern ME; Micallef J; Blin O
    Hum Psychopharmacol; 2006 Apr; 21(3):139-49. PubMed ID: 16625522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experience with the therapeutic use of grandaxin in neuroses].
    Kostiunina ZG; Eletskiĭ VIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(4):117-20. PubMed ID: 6124072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autonomic effect of grandaxin in the treatment of neurotic disorders in general somatic practice (lecture)].
    Aleksandrovskiĭ IuA; Avedisova AS; Pavlova MS
    Ter Arkh; 1998; 70(10):76-8. PubMed ID: 9864811
    [No Abstract]   [Full Text] [Related]  

  • 7. [The clinical characteristics of psychogenias in dental practice].
    Matveev VF; Klimov BA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(5):84-6. PubMed ID: 2168639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive zonisamide for treatment refractory anxiety.
    Kinrys G; Vasconcelos e Sa D; Nery F
    Int J Clin Pract; 2007 Jun; 61(6):1050-3. PubMed ID: 17504366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Generalized anxiety and neuroticism in patients suffering from somatic diseases].
    Małyszczak K; Pyszel A; Pawłowski T; Czarnecki M; Kiejna A
    Psychiatr Pol; 2008; 42(2):219-28. PubMed ID: 19697527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
    Rynn M; Russell J; Erickson J; Detke MJ; Ball S; Dinkel J; Rickels K; Raskin J
    Depress Anxiety; 2008; 25(3):182-9. PubMed ID: 17311303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of once daily parnaparin and unfractionated heparin in unstable angina pectoris: PRIME CARE study.
    PRIME CARE Study Investigators Group
    Indian Heart J; 2005; 57(6):648-54. PubMed ID: 16521631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of chronic neurotic illness in Nigeria.
    Jegede RO; Baiyewu O
    Afr J Med Med Sci; 1989 Mar; 18(1):13-20. PubMed ID: 2545078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
    Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial.
    Katzman MA; Vermani M; Jacobs L; Marcus M; Kong B; Lessard S; Galarraga W; Struzik L; Gendron A
    J Anxiety Disord; 2008 Dec; 22(8):1480-6. PubMed ID: 18455360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kava treatment in patients with anxiety.
    Geier FP; Konstantinowicz T
    Phytother Res; 2004 Apr; 18(4):297-300. PubMed ID: 15162364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anxiety state in patients during postinsult period with old cerebral infarction].
    Vashadze ShV; Beridze LA
    Georgian Med News; 2009 Jun; (171):47-53. PubMed ID: 19578214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical peculiarities of asthenic and dysthymic neurosis-like disorders in patients with alcoholism].
    Kolupaev GP; Chebotkov AA
    Voen Med Zh; 2000 Jul; 321(7):34-9. PubMed ID: 12886534
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of anxiolytic atarax as a substitutive drug for benzodiazepine tranquilizers].
    Avedisova AS; Iastrebov DV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(3):37-41. PubMed ID: 18379511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.